ANTIDOTE.ME
Antidote is a digital health company focused on accelerating and improving medical research. By combining proprietary technologies, data, and well-established business models, the company is transforming the way patients and researchers connect so that breakthroughs happen faster. Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. The company is based in the US and the UK.
ANTIDOTE.ME
Industry:
Biotechnology Health Care Health Diagnostics Medical Pharmaceutical
Founded:
2010-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.antidote.me
Total Employee:
51+
Status:
Active
Contact:
+442034758201
Email Addresses:
[email protected]
Total Funding:
52.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Domain Not Resolving Organization Schema IPv6 Google Apps For Business Microsoft Azure DNS
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Allcyte
Allcyte is a biotech start-up focused on precision medicine and drug development in a patient-centric way using high-content imaging and AI
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Advisors List
Current Employees Featured
Founder
Investors List
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Venture Round - Antidote.me
LBO France
LBO France investment in Venture Round - Antidote.me
Smedvig Capital
Smedvig Capital investment in Venture Round - Antidote.me
Octopus Ventures
Octopus Ventures investment in Venture Round - Antidote.me
Octopus Ventures
Octopus Ventures investment in Venture Round - Antidote.me
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Venture Round - Antidote.me
Smedvig Capital
Smedvig Capital investment in Venture Round - Antidote.me
Octopus Ventures
Octopus Ventures investment in Venture Round - Antidote.me
Smedvig Capital
Smedvig Capital investment in Series B - Antidote.me
Amadeus Capital Partners
Amadeus Capital Partners investment in Series B - Antidote.me
Newest Events participated
Official Site Inspections
http://www.antidote.me Semrush global rank: 668.93 K Semrush visits lastest month: 64.21 K
- Host name: 246.70.77.34.bc.googleusercontent.com
- IP address: 34.77.70.246
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
